BerGenBio ASA
BRRGF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $1 | $1 |
| - Cash | $140 | $156 | $150 | $436 |
| + Debt | $1 | $0 | $0 | $2 |
| Enterprise Value | -$136 | -$153 | -$148 | -$433 |
| Revenue | $1 | $0 | $0 | $1 |
| % Growth | 139.5% | -9% | -49.7% | – |
| Gross Profit | $1 | $0 | $0 | $1 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$134 | -$190 | -$301 | -$308 |
| % Margin | -15,816.7% | -53,559.3% | -77,356.8% | -39,793.2% |
| Net Income | -$139 | -$190 | -$299 | -$309 |
| % Margin | -16,424.8% | -53,785.6% | -76,763.2% | -39,976.4% |
| EPS Diluted | -11.65 | -19.95 | -38.65 | -40.36 |
| % Growth | 41.6% | 48.4% | 4.2% | – |
| Operating Cash Flow | -$153 | -$225 | -$288 | -$303 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$153 | -$225 | -$288 | -$303 |